Use of Tofacitinib in Difficult to Treat Clinically Amyopathic Dermatomyositis

    Andreas Funke
    Image of study
    TLDR Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.
    Clinically amyopathic dermatomyositis, characterized by skin symptoms without muscle involvement, can significantly impair quality of life and is often resistant to conventional treatments. A case report of a 42-year-old woman with this condition, who did not respond to multiple systemic therapies, showed that treatment with tofacitinib 5 mg twice daily led to significant improvement in skin lesions and hair regrowth within 2 months, without notable adverse effects. This suggests that JAK inhibitors like tofacitinib may be a viable option when other treatments fail.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 6 results

    Similar Research

    5 / 688 results